Target Name: M1AP
NCBI ID: G130951
Review Report on M1AP Target / Biomarker Content of Review Report on M1AP Target / Biomarker
M1AP
Other Name(s): Spermatogenesis associated 37 | Meiosis 1 arresting protein | D6Mm5e | C2orf65 | Spermatogenesis-associated protein 37 | Meiosis 1 associated protein, transcript variant 1 | SPATA37 | SPGF48 | Meiosis 1 arrest protein (isoform 1) | meiosis 1 associated protein | Meiosis 1-arresting protein | spermatogenesis associated 37 | M1AP variant 1 | Meiosis 1 arrest protein | meiosis 1 arresting protein | Meiosis 1-associated protein | M1AP_HUMAN

M1AP: A Potential Drug Target for Cancer and Other Diseases

Spermatogenesis is a crucial process in the life of an organism, responsible for the production of gametes, or reproductive cells, which are essential for reproduction. M1AP (Spermatogenesis associated protein 37) is a protein that plays a vital role in this process. It is a key regulator of spermatogonial stem cell (SSC) proliferation and differentiation, and its levels have been linked to various diseases, including cancer.

M1AP is a transmembrane protein that is expressed in a variety of tissues, including testes, ovaries, and brain. It is a protein that is known to be involved in the regulation of cell growth, apoptosis, and autophagy.

One of the key functions of M1AP is its role in spermatogonial stem cell (SSC) proliferation and differentiation. SSCs are a type of stem cell that have the ability to develop into gametes, or reproductive cells. M1AP plays a vital role in regulating the proliferation and differentiation of these cells by controlling the levels of several key genes.

One of the key genes that M1AP regulates is the gene encoding the protein, itself. M1AP has been shown to physically interact with the protein encoded by this gene, and has been shown to play a role in the regulation of its expression. This interaction between M1AP and this gene suggest that M1AP may be a potential drug target for the treatment of diseases that are caused by the regulation of this gene.

Another gene that M1AP has been shown to regulate is the gene encoding the protein, itself. M1AP has been shown to physically interact with the protein encoded by this gene, and has been shown to play a role in the regulation of its expression. This interaction between M1AP and this gene suggests that M1AP may be a potential drug target for the treatment of diseases that are caused by the regulation of this gene.

M1AP is also involved in the regulation of cell apoptosis, which is the process by which cells die as a normal part of the cell cycle. The regulation of cell apoptosis is a critical process that helps to ensure the integrity and survival of cells. M1AP is shown to play a role in this process by regulating the levels of several key genes that are involved in cell apoptosis.

M1AP is also involved in the regulation of autophagy, which is the process by which cells break down and recycle their own damaged or unnecessary components. Autophagy is an important process that helps to ensure the integrity and survival of cells. M1AP is shown to play a role in this process by regulating the levels of several key genes that are involved in autophagy.

In conclusion, M1AP is a protein that plays a vital role in the regulation of spermatogonial stem cell (SSC) proliferation and differentiation, as well as the regulation of cell apoptosis and autophagy. Its levels have been linked to various diseases, including cancer, and M1AP may be a potential drug target for the treatment of these diseases. Further research is needed to fully understand the role of M1AP in these processes and to determine its potential as a drug target.

Protein Name: Meiosis 1 Associated Protein

Functions: Required for meiosis I progression during spermatogenesis

The "M1AP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about M1AP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

M6PR | MAB21L1 | MAB21L2 | MAB21L3 | MAB21L4 | MACC1 | MACC1-DT | MACF1 | MACIR | MACO1 | MACORIS | MACROD1 | MACROD2 | MACROD2-AS1 | MACROH2A1 | MACROH2A2 | MAD1L1 | MAD2L1 | MAD2L1BP | MAD2L2 | MADCAM1 | MADD | MAEA | MAEL | MAF | MAF1 | MAFA | MAFA-AS1 | MAFB | MAFF | MAFG | MAFIP | MAFK | MAFTRR | MAG | MAGEA1 | MAGEA10 | MAGEA11 | MAGEA12 | MAGEA13P | MAGEA2 | MAGEA2B | MAGEA3 | MAGEA4 | MAGEA5P | MAGEA6 | MAGEA7P | MAGEA8 | MAGEA9 | MAGEA9B | MAGEB1 | MAGEB10 | MAGEB16 | MAGEB17 | MAGEB18 | MAGEB2 | MAGEB3 | MAGEB4 | MAGEB5 | MAGEB6 | MAGEB6B | MAGEC1 | MAGEC2 | MAGEC3 | MAGED1 | MAGED2 | MAGED4 | MAGED4B | MAGEE1 | MAGEE2 | MAGEF1 | MAGEH1 | MAGEL2 | MAGI1 | MAGI1-AS1 | MAGI1-IT1 | MAGI2 | MAGI2-AS3 | MAGI3 | MAGIX | MAGOH | MAGOH-DT | MAGOHB | MAGT1 | MAIP1 | MAJIN | Major histocompatibility complex (MHC) antigen | Major Histocompatibility Complex Class I | Major histocompatibility complex class II antigens | MAK | MAK16 | MAL | MAL2 | MALAT1 | Malate dehydrogenase | MALL | MALLP2 | MALRD1 | MALSU1 | MALT1